A Molecular Signature Predictive of Indolent Prostate Cancer

Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer

(2013) Timothy J. Wilt   ANNALS OF INTERNAL MEDICINE

FGFR1 Is Essential for Prostate Cancer Progression and Metastasis

(2013) F. Yang et al.   CANCER RESEARCH

Clonal Progression of Prostate Cancers from Gleason Grade 3 to Grade 4

(2012) A. G. Sowalsky et al.   CANCER RESEARCH

Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study

(2012) David Olmos et al.   LANCET ONCOLOGY

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

Beyond PSA: The Next Generation of Prostate Cancer Biomarkers

(2012) J. R. Prensner et al.   Science Translational Medicine

Role of Immediate Confirmatory Prostate Biopsy to Ensure Accurate Eligibility for Active Surveillance

(2012) Piruz Motamedinia et al.   UROLOGY

survcomp: an R/Bioconductor package for performance assessment and comparison of survival models

(2011) Markus S. Schröder et al.   BIOINFORMATICS

Active Surveillance for Prostate Cancer: Progress and Promise

(2011) Matthew R. Cooperberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience

(2011) Jeffrey J. Tosoian et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

(2011) Jack Cuzick et al.   LANCET ONCOLOGY

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression

(2011) Zhihu Ding et al.   NATURE

Molecular classification of prostate cancer using curated expression signatures

(2011) E. K. Markert et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA

(2011) S. A. Tomlins et al.   Science Translational Medicine

Molecular sampling of prostate cancer: a dilemma for predicting disease progression

(2010) Andrea Sboner et al.   BMC Medical Genomics

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Overtreatment of men with low-risk prostate cancer and significant comorbidity

(2010) Timothy J. Daskivich et al.   CANCER

Integrative Genomic Profiling of Human Prostate Cancer

(2010) Barry S. Taylor et al.   CANCER CELL

Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype

(2010) Srirupa Roy et al.   CELL CYCLE

Paths of FGFR-driven tumorigenesis

(2010) Victor D. Acevedo et al.   CELL CYCLE

Molecular genetics of prostate cancer: new prospects for old challenges

(2010) M. M. Shen et al.   GENES & DEVELOPMENT

Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer

(2010) Julia H. Hayes et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Overdiagnosis in Cancer

(2010) H. G. Welch et al.   JNCI-Journal of the National Cancer Institute

Meta-analysis of age-related gene expression profiles identifies common signatures of aging

(2009) João Pedro de Magalhães et al.   BIOINFORMATICS

Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005

(2009) H. G. Welch et al.   JNCI-Journal of the National Cancer Institute

Integrating differentiation and cancer: The Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis

(2008) Cory Abate-Shen et al.   DIFFERENTIATION